Jul 9 2024 Topics Corporations, Securities & Antitrust • Federalism • Law & Economics Blog Post Not Enforcing the Robinson-Patman Act is Lawless and Likely Harms Consumers Mark Meador News reports that the Federal Trade Commission is about to bring its first enforcement action...
Jul 10 2024 Video Fireside Chat with FTC Commissioner Melissa Holyoak Svetlana Gans, Melissa Holyoak Join us on Wednesday, July 10th at 12:00 PM ET for a special lunch panel...
Jul 23 2024 Video FedSoc Forums Litigation Update: US v. Apple Deborah A. Garza, Rebecca Haw Allensworth, Maureen K. Ohlhausen In March of this year, the U.S. Justice Department and 16 states filed a sweeping...
Jul 18 2024 Video FedSoc Forums FTC’s Interim Pharmacy Benefit Manager Report - Assessing Vigor Daniel J. Gilman, Rani A. Habash, Derek W. Moore, Mike Shor On July 9th, the Federal Trade Commission released a Staff Interim Report on the Pharmacy...
Jul 24 2024 Video FedSoc Forums FTC Negative Option, Junk Fee, and Commercial Surveillance Rulemakings Nina Frant, Svetlana Gans, Paul J. Ray, Randal M. Shaheen, Mary Sullivan Weighing Costs, Benefits and Litigation Risk in a Post-Chevron Environment Former FTC and OMB officials, joined by a longtime FTC practitioner, will discuss the current...
Jul 23 2024 Podcast FedSoc Forums Litigation Update: US v. Apple Deborah A. Garza, Rebecca Haw Allensworth, Maureen K. Ohlhausen In March of this year, the U.S. Justice Department and 16 states filed a sweeping...
Jul 24 2024 Podcast FedSoc Forums FTC Negative Option, Junk Fee, and Commercial Surveillance Rulemakings Nina Frant, Svetlana Gans, Paul J. Ray, Randal M. Shaheen, Mary Sullivan Weighing Costs, Benefits and Litigation Risk in a Post-Chevron Environment Former FTC and OMB officials, joined by a longtime FTC practitioner, will discuss the current...
Jul 18 2024 Podcast FedSoc Forums FTC’s Interim Pharmacy Benefit Manager Report - Assessing Vigor Daniel J. Gilman, Rani A. Habash, Derek W. Moore, Mike Shor On July 9th, the Federal Trade Commission released a Staff Interim Report on the Pharmacy...
Jul 31 2024 Topics Administrative Law & Regulation • Corporations, Securities & Antitrust • Law & Economics Blog Post Reviving the Robinson-Patman Act is Bad for Consumers: In Response to Mark Meador Lawrence J. Spiwak Among our nation’s antitrust laws, the Robinson-Patman Act of 1936 (RPA) is perhaps the most...
Aug 14 2024 Topics Constitution • Corporations, Securities & Antitrust • Separation of Powers Blog Post Major Questions About the FTC’s Junk Fee Rule Jeff Stier The Federal Trade Commission (FTC) is due to vote on the so-called “junk fee” rule by the...
Topics
Not Enforcing the Robinson-Patman Act is Lawless and Likely Harms Consumers
News reports that the Federal Trade Commission is about to bring its first enforcement action...
Fireside Chat with FTC Commissioner Melissa Holyoak
Svetlana Gans, Melissa Holyoak
Join us on Wednesday, July 10th at 12:00 PM ET for a special lunch panel...
Litigation Update: US v. Apple
Deborah A. Garza, Rebecca Haw Allensworth, Maureen K. Ohlhausen
In March of this year, the U.S. Justice Department and 16 states filed a sweeping...
FTC’s Interim Pharmacy Benefit Manager Report - Assessing Vigor
Daniel J. Gilman, Rani A. Habash, Derek W. Moore, Mike Shor
On July 9th, the Federal Trade Commission released a Staff Interim Report on the Pharmacy...
FTC Negative Option, Junk Fee, and Commercial Surveillance Rulemakings
Nina Frant, Svetlana Gans, Paul J. Ray, Randal M. Shaheen, Mary Sullivan
Weighing Costs, Benefits and Litigation Risk in a Post-Chevron Environment
Former FTC and OMB officials, joined by a longtime FTC practitioner, will discuss the current...
Litigation Update: US v. Apple
Deborah A. Garza, Rebecca Haw Allensworth, Maureen K. Ohlhausen
In March of this year, the U.S. Justice Department and 16 states filed a sweeping...
FTC Negative Option, Junk Fee, and Commercial Surveillance Rulemakings
Nina Frant, Svetlana Gans, Paul J. Ray, Randal M. Shaheen, Mary Sullivan
Weighing Costs, Benefits and Litigation Risk in a Post-Chevron Environment
Former FTC and OMB officials, joined by a longtime FTC practitioner, will discuss the current...
FTC’s Interim Pharmacy Benefit Manager Report - Assessing Vigor
Daniel J. Gilman, Rani A. Habash, Derek W. Moore, Mike Shor
On July 9th, the Federal Trade Commission released a Staff Interim Report on the Pharmacy...
Topics
Reviving the Robinson-Patman Act is Bad for Consumers: In Response to Mark Meador
Among our nation’s antitrust laws, the Robinson-Patman Act of 1936 (RPA) is perhaps the most...
Topics
Major Questions About the FTC’s Junk Fee Rule
The Federal Trade Commission (FTC) is due to vote on the so-called “junk fee” rule by the...